Drug to activate a sleep-control pathway for sleep apnea
Part of Brain & nervous system, Lungs & breathing clinical trials.
This early study tests a medicine that is meant to improve how your brain and breathing muscles work during sleep for obstructive sleep apnea (OSA). If you qualify, you would be monitored during sleep to see whether the treatment changes breathing events and oxygen levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have sleep apnea with more than 10 breathing events per hour while lying on your back during NREM sleep
- You do not have other major medical conditions besides well-controlled high blood pressure or mild diabetes
- You are not taking medicines that affect breathing, sleep/arousal, or muscle function
- You should be able to sleep lying on your back (supine) during the sleep study
- You are not allergic to any study medications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a “rescue” set of medicines for obstructive sleep apnea when two common treatments haven’t worked well enough. If you still have frequent breathing pauses during sleep, the study may test whether these medicines can reduce them and improve safety and symptoms.
This trial tests whether the medication trazodone can help people with moderate to severe obstructive sleep apnea (OSA). If you have OSA and are not taking certain medications or have other sleep disorders, you may be able to join.
This trial tests whether combining electrical stimulation (via an Inspire device you already have or will get) with two medications can better treat obstructive sleep apnea. You'll help researchers understand if this combination works better than the device alone.
This study tests whether atomoxetine and DAW2022 can improve how severe obstructive sleep apnea is. It may help by changing breathing patterns during sleep, measured through physiology tests.
This trial tests a new nerve-stimulation therapy called Neuromod to treat moderate-to-severe sleep apnea in people who do not have access to other treatments. If you qualify, you would be part of a study to see if this implant helps improve your breathing during sleep.
This study tests acetazolamide (a medicine that changes breathing chemistry) to see how it affects sleep quality and neurocognitive (brain/memory/attention) outcomes in adults with untreated moderate to severe sleep apnea. You may be eligible if you have significant sleep apnea but do not have certain safety risks or need to start standard sleep apnea treatment right away.
Hear when a new Obstructive Sleep Apnea trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.